COVAXIN

Results have not yet undergone peer review, findings are provisional, and the conclusions/final results may differ

COVAXIN is a highly purified and inactivated two dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with a…

Having a choice of COVID-19 vaccines is just the first step. Besides the logistics and pharmacovigilance to track AEFIs, the other…

Redkar Hospital is amongst the 12 facilities that are listed for human trials of Covaxin developed by Bharat Biotech International…

Three subjects were enrolled today The human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began at Rohtak's…

“Sechenov University has completed tests on volunteers of the world's first vaccine against Covid-19. The vaccine is safe,” the…

The article which has been published on the Vigyan Prasar portal said it could take anywhere between 15 to 18 months before a…

According to ICMR, there is a need to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment…

Presently, 12 institutes have been identified for the clinical trials and ICMR has asked them to enable subject enrolment by the…